Antimicrobial drug prescriptions in ambulatory care settings, United States, 1992-2000

Emerging Infectious Diseases

Volumn 9, Issue 4, 2003, Pages 432-437

  McCaig, Linda F ^a,b   Besser, Richard E ^a   Hughes, James M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEPHALOSPORIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; TETRACYCLINE;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ARTICLE; EMERGENCY WARD; MEDICAL CARE; OUTPATIENT; PRESCRIPTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; ADOLESCENT; ADULT; CLINICAL PRACTICE; HUMAN; MEDICINE; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SPECIALTIES, MEDICAL; UNITED STATES;

EID: 0038699546     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0904.020268     Document Type: Article

References (36)

1. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington: National Academy Press; 1992.
2. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064-73.
3. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials, and patients. JAMA 1997;278:944-4.
4. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med 1997;337:491-2.
5. Low DE, Scheld WM. Strategies for stemming the tide of antimicrobial resistance. JAMA 1998;279:394-5.
6. Burke JP. Antibiotic resistance - squeezing the balloon? JAMA 1998;280:1270-1.
7. Levy SB. Multidrug resistance - a sign of the times. N Engl J Med 1998;338:1376-8.
8. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
9. Reichler MR, Allphin AA, Breiman RF, Shreiber JR, Arnold JE, McDougal LK, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
10. Dowell SF. Principles of judicious use of antimicrobial agents for pediatric upper respiratory infections. Pediatrics 1998;101(Suppl 1):163-84.
11. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
12. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9. [Erratum: JAMA. 1998;279:434.]
13. Schappert SM. National Ambulatory Medical Care Survey: 1992 summary. Advance data from vital and health statistics; no. 253. Hyattsville (MD): National Center for Health Statistics; 1994.
14. Nyquist A, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections and bronchitis. JAMA 1998;279:875-7.
15. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901-4.
16. Jernigan D, Cetron M, Breiman R. Minimizing the impact of drug-resistant Streptococcuspneumoniae (DRSP): a strategy from the DRSP Working Group. JAMA 1996;275:206-9.
17. Besser RE How to alter prescription patterns: promoting appropriate antibiotic use. In: Soulsby L, Wilbur R, editors. Antimicrobial resistance. London: RSM Press; 2001:151-8.
18. McCaig LF, Besser RE, Hughes JM. Trends in pediatric antimicrobial drug prescribing among office-based physicians in the United States. JAMA 2002;287:3096-102.
19. Bryant E, Shimizu I. Sample design, sampling variance, and estimation procedures for the National Ambulatory Medical Care Survey. Vital Health Stat 2 1988;108:1-39.
20. McCaig LF, McLemore T. Plan and operation of the National Hospital Ambulatory Medical Care Survey. Vital Health Stat 1 1994;34:1-78.
21. Koch H, Campbell W. The collection and processing of drug information. National Ambulatory Medical Care Survey, 1980. Vital Health Stat 2 1982;2:1-90.
22. Physicians' desk reference. Montvale (NJ): Medical Economics Company, Inc; 1992.
23. McEvoy GK, editor. American Hospital Formulary Service: drug information 92. Bethesda (MD): American Society of Hospital Pharmacists; 1992.
24. Drug facts and comparisons. St. Louis: Lippincott; 1996.
25. McEvoy GK, editor. American Hospital Formulary Service: drug information 2000. Bethesda (MD): American Society of Hospital Pharmacists Inc.; 2000.
26. Shah BV, Barnwell BG, Hunt PN, La Vange LM. SUDAAN user's manual release 5.50. Research Triangle Park (NC): Research Triangle Institute; 1991.
27. Sirken MG, Shimizu I, French DK, Brock DB. Manual on standards and procedures for reviewing statistical reports. Hyattsville (MD): National Center for Health Statistics; 1990.
28. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347-82.
29. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001;134:479-86.
30. Hickner JM, Bartlett JC, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intem Med 2001;134:498-505.
31. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 2001:286;1857-62.
32. Ho PL, Yung RW, Tsang DN, Que TL, Ho M, Seto WH, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother 2001;48:659-65.
33. Gay K, Baughman W, Miller Y, Jackson D, Whitney CG, Schuchat A, et al. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J Infect Dis 2000;182:1417-24.
34. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada: Canadian Bacterial Surveillance Network. N Engl J Med 1999;341:233-9.
35. Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactum consumption in Spain (1979-1997). J Antimicrob Chemother 2000;46:767-73.
36. Pichichero ME. Dynamics of antibiotic prescribing for children. JAMA 2002;287:3133-5.